Andrew Alt

Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor

Neil T. Burford, Mary J. Clark, Tom S. Wehrman et al. · Proceedings of the National Academy of Sciences · 2013 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitro

Andrew Alt, Brianne Weiss, Ann Marie L. Ogden et al. · Neuropharmacology · 2004 · 126 citations

Life Sciences, Neuroscience, Pharmacology +17

Pharmacologic Evidence for a Putative Conserved Allosteric Site on Opioid Receptors

Kathryn E. Livingston, M. Alexander Stanczyk, Neil T. Burford et al. · Molecular Pharmacology · 2017 · 113 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Stimulation of Guanosine-5′-O-(3-[35S]Thio)Triphosphate Binding by Endogenous Opioids Acting at a Cloned Mu Receptor

Andrew Alt, Alfred Mansour, Huda Akil et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 101 citations

Medicine, Neuroscience, Pharmacology +17

Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist

Julia C. A. More, Robert Nisticò, Nigel P. Dolman et al. · Neuropharmacology · 2004 · 100 citations

Medicine, Neuroscience, Pharmacology +12